DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prostate Cancer Forecast in 18 Major Markets 2016-2026" report to their offering.
This report provides the current incident population for Prostate Cancer across 18 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Argentina, Australia, Canada, India, Mexico, Russian Federation, Saudi Arabia, South Africa, Turkey and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Prostate Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
Reason to buy:
- Able to quantify patient populations in global Prostate Cancer's market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the incidence of the subdivided types of Prostate Cancer and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on Prostate Cancer's incident population.
List of Tables and Figures
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Incidence for Prostate Cancer
Features of Prostate Cancer Patients
Prostate Cancer by Stage
Treated Prostate Cancer Patients by Hormonal Status
Abbreviations used in the Report
Other Black Swan Analysis Publications
Online Pricing Data and Platforms
For more information about this report visit http://www.researchandmarkets.com/research/qbc7k8/prostate_cancer